Robyn Lim
Publications by Year
Research Areas
Health Systems, Economic Evaluations, Quality of Life, Biomedical and Engineering Education, Biomedical Ethics and Regulation, Pharmaceutical Economics and Policy, Pharmaceutical studies and practices
Most-Cited Works
- → Adaptive Licensing: Taking the Next Step in the Evolution of Drug Approval(2012)268 cited
- → From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients(2015)186 cited
- → Accelerated Access to Innovative Medicines for Patients in Need(2014)86 cited
- → “Threshold‐crossing”: A Useful Way to Establish the Counterfactual in Clinical Trials?(2016)76 cited
- → SJS/TEN 2019: From science to translation(2020)74 cited
- → Real World Data in Adaptive Biomedical Innovation: A Framework for Generating Evidence Fit for Decision‐Making(2016)64 cited
- → Regulatory Decision Making in Canada—Exploring New Frontiers in Patient Involvement(2016)25 cited
- → Adaptive Biomedical Innovation: Evolving Our Global System to Sustainably and Safely Bring New Medicines to Patients in Need(2016)12 cited
- → The Janus initiative: A multi-stakeholder process and tool set for facilitating and quantifying Adaptive Licensing discussions(2014)8 cited
- → Rare diseases and space health: optimizing synergies from scientific questions to care(2022)5 cited